People born 1947-1951 invited for COVID-19 vaccination starting 6 April Starting Tuesday 6 April, the first people in the next age group will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1947 through 1951.
Single vaccination after COVID-19 infection within the past six months Starting today, people who tested positive for COVID-19 in the past six months can indicate when scheduling a vaccination appointment that they only want one vaccine dose.
Number of STIs continues to rise at Dutch STI clinics In the first half of this year more STIs were found in people who have been tested at Dutch STI clinics. The increase pertains to all STIs, with the exception of HIV.
European Antibiotic Awareness Day 2016 Friday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe attention focuses on the threat of antibiotic resistance to people and animals.
EU legislation genetically modified microbial biocontrol agents is fit for purpose EU legislative instruments are sufficient to ensure the safety of such products.
Surveillance and developments National Immunisation Programme 2015-2016 The report provides an overview of effectiveness and safety of vaccines and vaccine research.
RIVM starts field research into rubber granulate RIVM has started to take samples of rubber granulate from 100 synthetic turf fields in the Netherlands.
Need for strategy to assess endocrine disrupting chemicals There is a need for a strategy to enable companies and governments to assess whether chemicals are endocrine disrupting.
No health risks associated with foods and food supplements containing Krill and microalgae oils Consumption of foods and food supplements that contain oil from microalgae Schizochytrium sp. and Krill oil do not cause harm to our health.
No evidence of increased incidence of breast cancer with insulin glargine Insulin glargine is used in the treatment of diabetes.